Results 21 to 30 of about 31,946 (224)

Immunobiology of visceral leishmaniasis [PDF]

Frontiers in Immunology, 2012
Visceral leishmaniasis (VL), commonly known as kala-azar, is caused by Leishmania donovani and Leishmania infantum (Leishmania chagasi in the Americas). These Leishmania species infect macrophages throughout the viscera, and parasites are typically found in the spleen, liver, and bone marrow.
Kumar, Rajiv, Nylén, Susanne
openaire   +3 more sources

Diagnosis of visceral leishmaniasis [PDF]

Transactions of the Royal Society of Tropical Medicine and Hygiene, 2011
Leishmaniasis is a vector-borne disease with up to 350 million people at risk of infection worldwide. Among its different clinical manifestations, visceral is the most severe form. Since clinical features of visceral leishmaniasis (VL) mimic several other common diseases, accurate diagnosis is crucial as the treatment is associated with significant ...
Pankaj, Srivastava, Anand, Dayama, Sanjana, Mehrotra, Shyam, Sundar   +3 more
openaire   +2 more sources

Presentation of AIDS with Disseminated Cutaneous and Visceral Leishmaniasis in Iran

Case Reports in Infectious Diseases, 2015
Leishmaniasis is an infectious disease in form of visceral (VL), cutaneous (CL), and mucocutaneous (MCL) leishmaniasis. Immunocompromised patients have increased risk of Leishmania infection, especially in endemic areas for visceral leishmaniasis, where
Mohammadali Davarpanah, Masumeh Rassaei, Fatemeh Sari aslani   +2 more
doaj   +1 more source

Advances in leishmaniasis. [PDF]

, 2005
Governed by parasite and host factors and immunoinflammatory responses, the clinical spectrum of leishmaniasis encompasses subclinical (inapparent), localised (skin lesions), and disseminated infection (cutaneous, mucosal, or visceral).
Berman, Jonathan D, Murray, Henry W, Davies, Clive R, Saravia, Nancy G   +3 more
core   +1 more source

Treatment of visceral leishmaniasis

Journal of Global Infectious Diseases, 2010
The available treatment options for visceral leishmaniasis (VL) have problems relating to efficacy, adverse effects and cost, making treatment a complex issue. We review the evidence relating to the different methods of treatment in relation to - efficacy and toxicity of the drugs in different areas of the world; ability to monitor side effects, length
E M Moore, D N Lockwood
openaire   +4 more sources

Visceral leishmaniasis: current status of control, diagnosis, and treatment, and a proposed research and development agenda. [PDF]

, 2002
Visceral leishmaniasis is common in less developed countries, with an estimated 500000 new cases each year. Because of the diversity of epidemiological situations, no single diagnosis, treatment, or control will be suitable for all.
Croft, Simon L, Wasunna, Monique K, Boelaert, M, Bryceson, A. D. M., Olliaro, P, Guerin, Philippe J, Desjeux, Philippe, Croft, SL, Bryceson, Anthony DM, Guerin, Philippe J., Sundar, Shyam, Boelaert, M., Boelaert, Marleen, Guerin, PJ, Sundar, S, Guerin, P. J., Wasunna, MK, Bryceson, Anthony D. M., Croft, S. L., Wasunna, Monique K., Desjeux, P, Wasunna, M. K., Croft, Simon L., Olliaro, Piero, Oliaro, P., Desjeux, P., Sundar, S., Bryceson, AD   +27 more
core   +1 more source

Leishmaniasis: new approaches to disease control. [PDF]

, 2003
The leishmaniases afflict the world's poorest populations. Among the two million new cases each year in the 88 countries where the disease is endemic (fig 1), it is estimated that 80% earn less than $2 a day.
Croft, Simon L, Sundar, Shyam, Davies, Clive R., Croft, Simon L., Kaye, Paul, Davies, Clive R   +5 more
core   +1 more source

Domestic animals and epidemiology of visceral leishmaniasis, Nepal. [PDF]

, 2010
On the Indian subcontinent, visceral leishmaniasis (VL) is considered an anthroponosis. To determine possible reasons for its persistence during interepidemic periods, we mapped Leishmania infections among healthy persons and animals in an area of active
Gert Van der Auwera, De Doncker, Simonne, Khanal, Basudha, Speybroeck, Niko, Jean-Claude Dujardin, Bhattarai, N. R., Picado, Albert, Ostyn, B., Dujardin, J. C., Dujardin, Jean-Claude, Niko Speybroeck, Dujardin, Jean Claude, Clive Davies, Davies, C., Van der Auwera, G., Boelaert, M., Dirk Berkvens, Narayan Raj Bhattarai, Boelaert, Marleen, Bhattarai, Narayan Raj, Simonne De Doncker, Das, M. L., Das, Murari Lal, Davies, Clive, Rijal, S., Basudha Khanal, Bart Ostyn, Marc Coosemans, Khanal, B., Picado, A., Coosemans, Marc, Albert Picado, Marleen Boelaert, Berkvens, Dirk, Coosemans, M., Speybroeck, N., Van der Auwera, Gert, Rijal, Suman, De Doncker, S., Berkvens, D., Ostyn, Bart, Murari Lal Das, Suman Rijal   +42 more
core   +1 more source

Human visceral leishmaniasis and relationship with vector and canine control measures

Revista de Saúde Pública, 2018
OBJECTIVE Estimate the coverage of control measures of visceral leishmaniasis and relate them with the occurrence of human visceral leishmaniasis in endemic urban area.
Danielle Nunes Carneiro Castro Costa, Patricia Marques Moralejo Bermudi, Lilian Aparecida Colebrusco Rodas, Caris Maroni Nunes, Roberto Mitsuyoshi Hiramoto, José Eduardo Tolezano, Rafael Silva Cipriano, Graziela Cândido Diniz Cardoso, Cláudia Torres Codeço, Francisco Chiaravalloti Neto   +9 more
doaj   +1 more source

Transmission, reservoir hosts and control of zoonotic visceral leishmaniasis [PDF]

, 2009
Zoonotic visceral leishmaniasis (ZVL) caused by Leishmania infantum is an important disease of humans and dogs. Here we review aspects of the transmission and control of ZVL.
Courtenay, Orin, Quinnell, Rupert J., Quinnell, RJ, Courtenay, O   +3 more
core   +1 more source